Kathryn E. Falberg

Kathryn E. Falberg is recorded as Board Member at Nuvation Bio Inc. (NUVB). The newest filing on record that lists Kathryn E. Falberg as Board Member at Nuvation Bio Inc. (NUVB) is dated April 10, 2026. Kathryn E. Falberg was last confirmed as Board Member at UroGen Pharma Ltd. (URGN) in a filing dated April 28, 2021. Earlier roles on record: Board Member at Trade Desk, Inc. (TTD) until March 23, 2026. Trade Desk, Inc. reported in an 8-K filed March 25, 2026 that Kathryn E. Falberg resigned as the Board, effective March 23, 2026. Nuvation Bio Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Nuvation Bio Inc. includes David Hung (CEO and Board Member), Moses Makunje (CFO and Chief Accounting Officer), Philippe Sauvage (CFO) and 7 others.